
TY  - JOUR
AU  - CONRAD, STEVEN A.
AU  - Bagley, Ann
AU  - Bagley, Barry
AU  - SCHAAP, ROBERT N.
TI  - Major Findings from the Clinical Trials of the Intravascular Oxygenator
JO  - Artificial Organs
VL  - 18
IS  - 11
SN  - 0160-564X
UR  - https://doi.org/10.1111/j.1525-1594.1994.tb03334.x
DO  - doi:10.1111/j.1525-1594.1994.tb03334.x
SP  - 846
EP  - 863
KW  - IVOX
KW  - Intravascular oxygenation
KW  - Clinical trials
KW  - Acute respiratory failure
PY  - 1994
AB  - Abstract: Major clinically relevant findings have been extracted and summarized from the database developed from the international multicenter clinical trials of the intravascular oxygenator (IVOX) as a means for augmenting the deficient blood gas transfer of patients in advanced acute respiratory failure (ARF). Between February 1990 and May 1993, a total of 164 IVOX devices were utilized in 160 clinical trial patients who were hypoxemic and/or hypercarbic while receiving closed system positive pressure mechanical ventilator support at or exceeding generally accepted minimum safe levels of intensity. The average rates of oxygen and carbon dioxide transfer into and out of circulating venous blood by means of the IVOX device varied from 40?70 ml/min. Evidence of patient benefit during IVOX utilization includes improvement in blood gas partial pressures associated with decreased intensity of mechanical ventilation, improved hemodynamics in patients with mechanical ventilator depressed cardiovascular function, and decreased indices of lung dysfunction. Clinically recognized IVOX?related complications or adverse events were reported in 24. 5% of the clinical trials patients. At necropsy examination of 68 clinical trials patients who died during or after I VOX utilization, forensic pathologists reported 4 cases in which IVOX utilization could have been a primary or contributing cause of death. Significant IVOX device mechanical and/or performance malfunction problems were recognized in 29 (17. 7%) of the IVOX devices utilized in clinical trials. IVOX clinical trials data collected and analyzed to date indicate IVOX utilization has a favorable risk/benefit ratio in patients in severe, acute, potentially reversible ARF.
ER  - 

TY  - JOUR
TI  - ASBMR 2010 Annual Meeting SA0001–SA0485
JO  - Journal of Bone and Mineral Research
JA  - J Bone Miner Res
VL  - 25
IS  - S1
SN  - 0884-0431
UR  - https://doi.org/10.1002/jbmr.5650251303
DO  - doi:10.1002/jbmr.5650251303
SP  - S136
EP  - S224
PY  - 2010
ER  - 

AU  - Skinner, Adam
AU  - Horton, Stephen B.
AU  - Motta, Pablo
AU  - Stayer, Stephen
C7  - pp. 751-776
TI  - Mechanical Support of the Circulation
SN  - 9781118768259
UR  - https://doi.org/10.1002/9781118768341.ch32
DO  - doi:10.1002/9781118768341.ch32
SP  - 751-776
KW  - Extracorporeal Membrane Oxygenation (ECMO)
KW  - Ventricular Assist Device (VAD)
KW  - Left Ventricular Assist Device (LVAD)
KW  - Right Ventricular Assist Device (RVAD)
KW  - Biventricular Assist Device (BiVAD)
KW  - Extracorporeal Life Support (ECLS)
KW  - Extracorporeal Cardiopulmonary Resuscitation (ECPR)
KW  - Extracorporeal Life Support Organization (ELSO)
KW  - Low Cardiac Output State (LCOS)
KW  - Respiratory Failure
KW  - Veno-arterial (VA) cannulation
KW  - Veno-veno (VV) cannulation
PY  - 2010
AB  - Summary Mechanical devices used to support the failing heart or respiratory systems continue to improve and their use is continuing to increase. As outcomes have improved the number of indications for use has increased and the threshold for use continues to decline, recognizing that a persistent low cardiac output state has greater risk of organ injury or death than institution of mechanical support of the circulation. Likewise, higher pressure of mechanical ventilator support can produce greater injury to the lung than the use of extracorporeal membrane oxygenation. The most rapid area of advancement is in the long-term use of ventricular assist devices. Children with previous terminal conditions can now be supported for many months and eventually undergo heart transplantation if their heart does not recover. Echocardiography plays an essential role in determining when mechanical support of the circulation is indicated, and for accurate placement and de-airing of devices. With the smaller surface area of new mechanical devices, there is less blood exposure to artificial surface and therefore reduced need for anticoagulation; however, thromboembolic and bleeding complications remain relatively high.
ER  - 

TY  - JOUR
TI  - Abstract
JO  - Journal of Thrombosis and Haemostasis
JA  - Journal of Thrombosis and Haemostasis
VL  - 5
IS  - S2
SN  - 9781118768259
UR  - https://doi.org/10.1111/j.1538-7836.2007.tb00018.x
DO  - doi:10.1111/j.1538-7836.2007.tb00018.x
SP  - P-M-010
EP  - P-M-327
PY  - 2007
ER  - 

TY  - JOUR
TI  - Oral Abstracts
JO  - American Journal of Transplantation
VL  - 18
IS  - S4
SN  - 9781118768259
UR  - https://doi.org/10.1111/ajt.14917
DO  - doi:10.1111/ajt.14917
SP  - 245
EP  - 478
PY  - 2018
ER  - 

AU  - Shah, Neil
AU  - Goodnough, Lawrence Tim
C7  - pp. 344-357
TI  - Coagulation factor concentrates and pharmacologic therapies for acquired bleeding disorders
SN  - 9781119012993
UR  - https://doi.org/10.1002/9781119013020.ch30
DO  - doi:10.1002/9781119013020.ch30
SP  - 344-357
KW  - bleeding
KW  - fibrinogen
KW  - heparin
KW  - platelet
KW  - therapy
KW  - coagulation
KW  - warfarin
PY  - 2018
AB  - Summary Limitations to successful plasma therapy include constraints related to inventory, turnaround time, and volumes infused. For PCCs, availability of four-factor PCCs may be limited, and three-factor PCCs are not approved for replacement of the vitamin K-dependent clotting factors, except for factor IX. Close collaboration among critical care specialists, hematology, transfusion medicine, and pharmacy services is desirable for management of patients with complex coagulopathies. In the absence of clearly supportive evidence, physicians should exercise restraint in the use of rFVIIa in off-label settings. Physicians need to be encouraged to adapt their clinical practices with sound clinical evidence for use of each of the hemostatic/prothrombotic products.
ER  - 

TY  - JOUR
AU  - Mealey, Brian L.
TI  - Periodontal Implications: Medically Compromised Patients
JO  - Annals of Periodontology
JA  - Annals of Periodontology
VL  - 1
IS  - 1
SN  - 9781119012993
UR  - https://doi.org/10.1902/annals.1996.1.1.256
DO  - doi:10.1902/annals.1996.1.1.256
SP  - 256
EP  - 321
PY  - 1996
ER  - 

TY  - JOUR
C7  - e28077
TI  - Abstracts from the 35th Annual Meeting of the Histiocyte Society, Memphis, TN, USA, November 3–5, 2019
JO  - Pediatric Blood & Cancer
JA  - Pediatr Blood Cancer
VL  - 67
IS  - S1
SN  - 9781119012993
UR  - https://doi.org/10.1002/pbc.28077
DO  - doi:10.1002/pbc.28077
SP  - e28077
PY  - 2020
ER  - 

TY  - JOUR
TI  - Abstracts from the Seventh International Conference on Pediatric Mechanical Circulatory Support Systems and Pediatric Cardiopulmonary Bypass
JO  - Artificial Organs
VL  - 35
IS  - 4
SN  - 9781119012993
UR  - https://doi.org/10.1111/j.1525-1594.2011.01247.x
DO  - doi:10.1111/j.1525-1594.2011.01247.x
SP  - A1
EP  - A26
PY  - 2011
ER  - 

TY  - JOUR
TI  - Abstracts of The Movement Disorder Society's Eleventh International Congress of Parkinson's Disease and Movement Disorders
JO  - Movement Disorders
JA  - Mov. Disord.
VL  - 22
IS  - S16
SN  - 9781119012993
UR  - https://doi.org/10.1002/mds.21535
DO  - doi:10.1002/mds.21535
SP  - S1
EP  - S325
PY  - 2007
ER  - 

TY  - JOUR
TI  - Administrative Operations Section
JO  - Transfusion
VL  - 45
IS  - s3
SN  - 9781119012993
UR  - https://doi.org/10.1111/j.1537-2995.2005.00629_2.x
DO  - doi:10.1111/j.1537-2995.2005.00629_2.x
SP  - 152A
EP  - 204A
PY  - 2005
ER  - 

TY  - JOUR
TI  - Abstracts of the 58th Annual Meeting of the Scientific and Standardization Committee of the International Society on Thrombosis and Haemostasis June 27 – 30, 2012
JO  - Journal of Thrombosis and Haemostasis
JA  - J Thromb Haemost
VL  - 11
IS  - s3
SN  - 9781119012993
UR  - https://doi.org/10.1111/jth.12443
DO  - doi:10.1111/jth.12443
SP  - 1
EP  - 105
PY  - 2013
ER  - 

TY  - JOUR
TI  - Concurrent Abstracts Session Four: Wednesday 25th May 0900‖1030
JO  - Journal of Paediatrics and Child Health
JA  - Journal of Paediatrics and Child Health
VL  - 52
IS  - S2
SN  - 9781119012993
UR  - https://doi.org/10.1111/jpc.13194_3
DO  - doi:10.1111/jpc.13194_3
SP  - 78
EP  - 104
PY  - 2016
ER  - 

TY  - JOUR
TI  - Non- Moderated Posters
JO  - BJU International
VL  - 94
IS  - s2
SN  - 9781119012993
UR  - https://doi.org/10.1111/j.1465-5101.2004.05080.x
DO  - doi:10.1111/j.1465-5101.2004.05080.x
SP  - 163
EP  - 309
PY  - 2004
ER  - 

TY  - JOUR
TI  - ACR Meeting
JO  - Arthritis & Rheumatism
JA  - Arthritis & Rheumatism
VL  - 64
IS  - S10
SN  - 9781119012993
UR  - https://doi.org/10.1002/art.37735
DO  - doi:10.1002/art.37735
SP  - S1
EP  - S1216
PY  - 2012
AB  - Abstract http://acrmeeting.wiley.com/
ER  - 

C7  - pp. 201-223
TI  - Patterns of Non-Accidental Injury: Neglect
SN  - 9780813815015
UR  - https://doi.org/10.1002/9780470344583.ch11
DO  - doi:10.1002/9780470344583.ch11
SP  - 201-223
KW  - continuum
KW  - starvation
KW  - lymphocyte
KW  - hyperuricemia
KW  - cannibalism
PY  - 2012
AB  - Summary This chapter contains sections titled: Introduction Environment Examination Starvation Animal Hoarders Heat Stroke Hypothermia Embedded Collars Demodicosis Untreated Injuries
ER  - 

TY  - JOUR
TI  - 2017 ACR/ARHP Annual Meeting Abstract Supplement
JO  - Arthritis & Rheumatology
JA  - Arthritis & Rheumatology
VL  - 69
IS  - S10
SN  - 9780813815015
UR  - https://doi.org/10.1002/art.40321
DO  - doi:10.1002/art.40321
SP  - 1
EP  - 4481
PY  - 2017
AB  - Abstract For a searchable version of these abstracts, please visit www.acrabstracts.org.
ER  - 

TY  - JOUR
TI  - FREE COMMUNICATIONS  POSTER COMMUNICATIONS
JO  - Nephrology
VL  - 10
IS  - s1
SN  - 9780813815015
UR  - https://doi.org/10.1111/j.1440-1797.2005.00419.x
DO  - doi:10.1111/j.1440-1797.2005.00419.x
SP  - A1
EP  - A116
PY  - 2005
ER  - 

C7  - pp. 115-130
TI  - Patterns of Non-Accidental Injury: Burns
SN  - 9780813815015
UR  - https://doi.org/10.1002/9780470344583.ch7
DO  - doi:10.1002/9780470344583.ch7
SP  - 115-130
KW  - residue testing
KW  - erythema
KW  - histopathological
KW  - electrocution
KW  - hippocampus
PY  - 2005
AB  - Summary This chapter contains sections titled: Interpreting Burn Patterns Collection of Evidence Burn Classification Systemic Effects of Burns General Histopathological Findings in Burns Thermal Burns Chemical Burns Electrical Burns Fires: Thermal Injury and Smoke Inhalation
ER  - 

TY  - JOUR
TI  - Scientific Abstracts and Sessions
JO  - Medical Physics
JA  - Med. Phys.
VL  - 45
IS  - 6
SN  - 9780813815015
UR  - https://doi.org/10.1002/mp.12938
DO  - doi:10.1002/mp.12938
SP  - e120
EP  - e706
PY  - 2018
ER  - 
